Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Mod Pathol. 2022 Feb 18;35(8):1045–1054. doi: 10.1038/s41379-022-01024-8

Fig. 4. Impact of combined p16, OP-TIL OS and MN on overall survival (OS) and locoregional control (LRC).

Fig. 4

Analysis performed using Kaplan–Meier analysis coupled to log-rank test. LR = patients with low-risk MuNI and OP-TIL scores and p16 positive tumors; HR = patients with high-risk MuNI and OP-TIL scores and p16 negative tumors.